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 Introduction
Brucellosis, especially caused by Brucella melitensis, is
recognized as a significant public health challenge, with a
major economic and financial burden in countries where the
disease remains endemic [6-8, 13, 20]. In the Mediterranean
region as well as in Middle East, parts of Africa, Western
Asia and Latin America, B. melitensis infections in  small
ruminants are still widespread, resulting in significant human
illness, primarily from consumption of contaminated dairy
products or from occupational exposure to infected livestock
[6-8, 11, 13, 15, 18-21]. 
In small ruminants, contagious abortion, reduced fertility
and economic losses in terms of milk are the major impacts.
B. melitensis is enzootic in different regions of Palestine and
is the main cause of abortion in small ruminants [3, 10].
Brucellosis in Palestine is mainly diagnosed based on clinical
signs, serological and bacteriological investigations. Up to
now, no article has documented the molecular characterization
of the circulating B. melitensis population in Palestine. This
characterization has a pivotal role in epidemiological studies,
management of the outbreaks and implementing control and
preventive measures. The present study aimed to obtain a
snapshot of Brucella infections in the West Bank (Palestine),
to explore the prevalence of these strains in small ruminants
of infected flocks and to molecularly characterize B. meli-
tensis strains circulating in Palestine. 
Materials and Methods
ANIMAL SAMPLES AND SEROLOGICAL ANALYSES 
A total of 350 sera and 80 milk samples collected from
infected flocks in the West Bank, Palestine between January
and December 2008, were classified as seropositive based on
a positive reaction to one or both of the following tests: 1)
rose Bengal test (RBT); and 2) complement fixation test
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(CFT) carried out according to ALTON et al. [2]. All milk
samples were obtained from seropositive animals.
BACTERIOLOGICAL ANALYSIS OF MILK SAMPLES 
The cream and sediment mixtures from each of the 80 milk
samples from seropositive small ruminants were assessed
after centrifugation of milk samples (10 mL) at 2 000g, 4°C
for 20 minutes. Cream and sediment were then spread onto
Brucella agar plates (Oxoid Ltd., Hampshire, UK), incubated
at 37°C in 10% CO2 for 5 to 10 days then plates were daily
examined for the colony presence and identification accor-
ding to standard methods adapted by QUINN et al. [17].
PCR ASSAY AND SEQUENCING 
Genomic DNA was extracted from milk samples and from
positive milk cultures using the Nucleospin tissue kit
(Clonetech, Germany) according to the manufacturer’s
instructions.
PCR assay was performed in a 50 μL volume reaction
mixture containing 10 mM Tris-HCl (pH 8.4), 50 mM KCl,
1 mM MgCl2, 200 μM each deoxyribonucleotide tri-
phosphate (dATP, dGTP, dTTP, dCTP, Pharmacia LKB
Biotechnology, Uppsala, Sweden), 0.5 U of Taq polymerase
(Promega, Madison, WI, U.S.A.), and 10 nM of each primer
(syntezza, Israel). The primers were genus-specific primer
pairs designed to amplify the IS711 gene of the genus
Brucella (Table I). The cycling condition included an initial
denaturation step at 95°C for 120 seconds and then templates
were cycled 35 times (30 seconds of denaturation at 95°C, 45
seconds of annealing at 51°C and 30 seconds of extension at
72°C) with a final extension step at 72°C for 6 minutes by a
Master Cycler (BioRad Laboratories Inc., Hercules, CA).
The positive control contained DNA isolated from Rev.1
strain of B. melitensis as the template, and the negative
control consisted of sterile water instead of the DNA tem-
plate. The PCR products were resolved by electrophoresis on
2% agarose gel with ethidium bromide (0.5 mg/mL).
Two of the B. melitensis field isolates (1/P and 2/P) were
used to amplify and sequence a putative ORF in the hae-
magglutinin (HA) gene. The oligonucleotide primers used
for this purpose are listed in Table I. After PCR assay (as des-
cribed above) and agarose 2% gel electrophoresis, the PCR
products were purified using the MinElute PCR purification
kit (Qiagen, Germany) and the inserts were sequenced by a
dideoxy chain termination method on an ABI PRISM Model
301 Sequence Instrument at Bethlehem University,
Bethlehem, Palestine.
The alignment of DNA sequences and the comparisons
with other sequences were performed using the version
2.2.23 of BLAST. The phylogenic relationships between the
Brucella isolates and selected reference Brucella originated
from different Mediterranean countries were conducted
using the CLC Main Workbench software (version 5.6.1,
2009). The nucleotide sequences of the two B. melitensis
field isolates (1/P and 2/P) from Palestine reported here have
been submitted to the GenBank accession number and were
assessed as HM345998 and HM598409, respectively.
Results
Among the 350 sera from infected flocks in the West Bank
(Palestine) tested in the present study for detecting Brucella
antibodies, 129 (36.8%) and 113 (32.3%) were positive for
RBT and CFT, respectively (Table II). A comparison bet-
ween the RBT and CFT results showed that 102 animals
(29.1%) were positive in both tests and 210 (60.0%) were
negative in both tests, leading to an agreement score (num-
ber of similar results with both tests) of 89.1%.
By testing milk samples obtained from 80 serologically
positive animals, all the 38 (47.5%) positive ruminants detected
by bacterial isolation were also detected as positive by the
PCR assay (Table III). Furthermore, 24 (30.0%) additional
milk samples (that were negative for the bacterial isolation)
gave positive results with the PCR assay, and the frequency
of Brucella spp. in milk samples from seropositive small
ruminants determined by this method reached 77.5%.
Consequently, the agreement score between the bacterial iso-
lation and the PCR assay was moderate (70.0%). Moreover,
B. melitensis was identified in 42 PCR-positive milk samples,
leading to a high prevalence (67.7%) - of this specie - among
Brucella spp. in milk samples.
The DNA sequence of the haemagglutinin gene ORFs
from field isolates 1/P and 2/P were identical to the recently
identified sequence of type strain of B. melitensis (ATCC
23457, GenBank access no: CP001489), confirming that the
isolates belonged to the genus Brucella. The results of a
maximum likelihood phylogenic analysis by creating a cluster
Primer types Oligonucleotide sequences (5'-3') Amplified product
Brucella- primer Forward: G GTTGTTAAAGGAGAACAGC 600 bp
Reverse: GACGATAGCGTTTCAACTTG
B. melitensis- Forward: AAATCGCGTCCTTGCTGGTCTGA 731 bp
specific primer Reverse: TGCCGATCACTTAAGGGCCTTCAT
HA-ORFs Forward: GAACCAGAATACGGCAAAA 2 000 bp
(DNA sequence) Reverse: GTCGTTTCTGCGTCAACAGA
TABLE I: Sequences of primers for Brucella used in the present study.
HA: haemagglutinin gene.
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tree of the current isolate with other GenBank-accessible
gene sequences of B. melitensis isolated from several
Mediterranean countries are shown in figure 1. This tree
sorts the Brucella sequences studied here into three lineages,
named 1, 2 and 3. Although the tree is technically branching,
the shortness and suboptimal support of those branches in the
lineage n° 1 suggest a higher average of similarity between
France / Spain / Israel / Palestine (isolates 1 and 2) and
Cyprus Brucella strains; they appear to have radiated explo-
sively. This tree has also showed, as expected, that the strain
with an accession number AY518304 which belongs to
Israeli strains is the closest relative to the Brucella field iso-
lates in the present study. 
Discussion
Brucellosis, particularly caused by B. melitensis, is consi-
dered as one of the major zoonosis in Palestine. The
Palestinian Brucellosis Control Program started in 1998,
adopting the strategy of a mass vaccination of sheep and
goats (all ages and both sexes) via the conjunctival route
using full dose Rev.1 vaccine, but despite this, the sheep and
goat prevalence remained at approximately 4.8% and the
flock/herd prevalence at 46.3% in 2005 [7]. In the present
study, serological RBT and CFT tests showed different sen-
sitivities (36.8% and 32.3%, respectively). It is interesting to
note the discrepancies with the serological results, reflecting
by a moderate agreement score (89.1%): indeed, 102 (29.1%)
and 210 (60.0%) sera samples were simultaneously positive
and negative respectively, in both tests whereas 11 samples
(3.1%) were RBT-negative and CFT-positive and 27 (7.7%)
were RBT-positive and CFT-negative; despite these discre-
pancies between the 2 serological methods observed in the
present study and in others [4, 14] and the probable overes-
timation of the brucellosis seroprevalence throughout the
RBT, the results evidenced a high brucellosis seroprevalence
in small ruminants and confirm in one hand that the disease
is endemic in Palestine and should not to be underestimated
and on the other hand, that it was impossible to detect all
infected animals using a single serological test [4, 12].
Because the positive detection of specific DNA, as well as
the bacteriological isolation of Brucella, is a certain indication
of the presence of the pathogen, the feasibility of molecular
assays as diagnostic tools for brucellosis was evaluated in the
present study. The PCR assay has allowed the infection
detection in 77.5% of milk samples from seropositive ani-
mals, while Brucella species could be isolated in only 47.5%
samples. The low sensitivity of the culture method has already
been reported [5, 9]. The higher sensitivity of the PCR assay
can be explained by the fact that it detects DNA from bacteria
that are damaged and nonviable and therefore impossible to
isolate by conventional cultures. Interestingly, 22.5% (18/80)
FIGURE 1: A distance phylogenic tree based on the partial nucleotide
sequences of the ORFs sequences of haemagglutinin gene of two
selected B. melitensis field isolates and GenBank-accessible gene
sequences of B. melitensis isolated from several Mediterranean
countries (I, Israel; F, France; S, Spain; C, Cyprus, T, Turkey).
Horizontal distances are proportional to the genetic distances. The
tree is rooted by the version 5.6.1 of CLCL Main Workbench.
RBT Total
positive negative
CFT positive 102 (29.1%) 11 (3.1%) 113 (32.3%)
negative 27 (7.7%) 210 (60.0%) 237 (67.7%)
Total 129 (36.8%) 221 (63.1%) 350
TABLE II: Frequencies of serum anti-brucella antibodies detected by RBT (Rose Bengal Test) and CFT (Complement Fixation Test)
in 350 cattle from infected farms.
Bacterial isolation Total
positive negative
PCR positive 38 (47.5%) 24 (35.0%) 62 (77.5%)
assay negative 0 (0.0%) 18 (22.5%) 18 (22.5%)
Total 38 (47.5%) 42 (52.5%) 80
TABLE III: Detection of Brucella spp. in milk samples by bacterial isolation and PCR assay recovered from 80 serologically positive
cows.
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of milk samples from seropositive small ruminants were
PCR negative in this study. This discrepancy could be related
to a lack of sensitivity of the PCR technique, to serologically
false results or also to an earlier contact with bacteria suffi-
cient to induce a specific and persistent humoral immune
response whereas the pathogen has been eliminated from the
organism. However, because the natural immunization in
sheep and goats was in fact often coupled to a latent infec-
tion without a total elimination of the brucella and because
of the occurrence of frequent serological cross-reactivity
with other bacteria such as Yersinia enterocolitica O:9,
Francisella tularensis, Escherichia coli O:157, Salmonella
urbana group N, Vibrio cholerae and Stenotrophomonas
maltophilia [1, 9, 16], it is highly likely that a great number
of these samples were indeed false positives for brucellosis.
In the present study, the phylogenic analysis (figure 1)
strongly suggested that the two Palestinian Brucella field
isolates and the Brucella isolates from the Israel, France,
Cyprus and Spain are closely related. In addition, as expected,
the Israelian strain identified as AY518304 was the most
strongly similar to the 2 Palestinian B. melitensis strains (1/P
and 2/P isolates), confirming anterior brucella contamination
of sheep and goats from Israel to Palestine. 
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